SCHEMBL4852236

SCHEMBL4852236

CCOc1ccccc1/C=C/C(=O)c1cc(-c2ccccc2C)ccc1OCCN(C)C

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.48
SLC6A9 P48067 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
ATM Q13315 1/20 0.45
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 2/20 0.43
CAPN1 P07384 1/20 0.41
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
HRH1 P35367 1/20 0.40
ESR1 P03372 1/20 0.40
XDH P47989 1/20 0.40
HTR7 P34969 1/20 0.40
TNFRSF1A P19438 1/20 0.40
PTPN11 Q06124 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4853461 1.00 AR (0.48) ARSLC6A9SMN1; SMN2LMNAMAPT
SCHEMBL4852241 0.93 SLC6A9 (0.45) ARSLC6A9SMN1; SMN2LMNAMAPT
SCHEMBL4853568 0.88 SLC6A9 (0.46) ARSLC6A9SMN1; SMN2ALDH1A1KDM4E
SCHEMBL4847435 0.88 SLC6A9 (0.46) ARSLC6A9SMN1; SMN2ALDH1A1KDM4E
SCHEMBL4845755 0.88 AR (0.49) ARSLC6A9SMN1; SMN2LMNAMAPT
SCHEMBL4853937 0.88 AR (0.49) ARSLC6A9SMN1; SMN2LMNAMAPT
SCHEMBL4855044 0.85 SLC6A9 (0.46) ARSLC6A9SMN1; SMN2ALDH1A1KDM4E
SCHEMBL4854689 0.85 SLC6A9 (0.46) ARSLC6A9SMN1; SMN2ALDH1A1KDM4E
SCHEMBL4850162 0.85 CHRNA7 (0.51) SLC6A9SMN1; SMN2LMNAALDH1A1HTR7
SCHEMBL4853325 0.85 CHRNA7 (0.51) SLC6A9SMN1; SMN2LMNAALDH1A1HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed